86exporter.com Home       Products Catalog      Suppliers Catalog      Log In        Sign up
      About Us
      Profile
      Products
      Contact Us


Shenzhen Nexconn Pharmatechs Ltd

Products >> Dabigatran etexilate mesylate

Dabigatran etexilate mesylate

Build Your Online Product Catalogs?



Description
Product Name: Dabigatran etexilate mesylate
Supply Ability:
Related proudcts ***xa,
Specifications 99%+ purity, unknown single impurity<0.1%
Price Term: according to the customers' requests
Port of loading: according to the customers' requests
Minimum Order
Unit Price:

Dabigatran etexilate mesylate was first approved by EMA on May 18,2008, then approved by the USA FDA on Oct 19,2010, and approved by P*** on Jan 21,2011. It was developed and marketed as ***xa by Boehringer Ingelheim in DE and GB. Blood system API; Anti-clotting drugs; Used in patients with nonvalvular atrial fibrillation reduce the risk of stroke and systemic embolism. Darby and group of ester is a new kind of synthesis of direct thrombin inhibitor, is the precursor of dabigatran, of non peptide thrombin inhibitors. Oral gastrointestinal absorption.

Contact Us
Company: Shenzhen Nexconn Pharmatechs Ltd
Contact: Mr. Jason Scorpion
Address: Rm.1249-1251, Jiaxiye Plaza, No.318 Minzhi Ave., Longhua New Dist
Postcode: 518131
Tel: +86-755-89396905
Fax: +86-755-22712255
E-mail:         


Copyright© Shenzhen Nexconn Pharmatechs Ltd All Rights Reserved.
Tel : +86-755-89396905 Fax : +86-755-22712255
Powered by 86exporter.com